Literature DB >> 2997987

Characterization and chromosomal distribution of endogenous mouse mammary tumor viruses of European mouse strains STS/A and GR/A.

R Michalides, R Verstraeten, F W Shen, J Hilgers.   

Abstract

The endogenous mouse mammary tumor virus (MMTV) proviral copies in two genetically dissimilar mouse strains, STS/A, a European mouse strain, and BALB/c, were characterized. STS/A carries the same four MMTV proviral copies as GR.Mtv-2-; these strains share also most of the isoenzyme markers and are therefore highly related. Cellular DNA of GR.Mtv-2- contains a partial MMTV provirus that is not present in STS/A. GR.Mtv-2- is derived from GR; they differ in the locus Mtv-2 that contains one MMTV provirus. Expression of this Mtv-2 endogenous MMTV provirus is directly linked to mammary tumorigenesis in GR. MMTV proviral loci were studied using restriction enzyme analysis and the Southern transfer procedure using liver DNAs from recombinant inbred strains between BALB/c and STS/A. All segregating MMTV-specific EcoRI fragments were identified to MMTV proviral loci and most of these were localized by studying the cosegregation of the Mtv units and known chromosomal markers. Since STS/A, GR.Mtv-2-, and GR are highly related, the five complete endogenous MMTV proviruses of GR were located on the following chromosomes: Mtv-2 on chromosome 18, Mtv-3 on 11, Mtv-19 on 1, Mtv-20 on 4, whereas Mtv-8 has tentatively been located on chromosome 18 by Callahan et al. (R. Callahan, D. Gallahan, and Ch. Kozak (1984), J. Virol. 49, 1005-1008). GR and GR.Mtv-2 furthermore contain two incomplete MMTV proviral elements, one of which is also present in STS/A.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997987     DOI: 10.1016/0042-6822(85)90336-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

Review 1.  Mouse chromosome 18.

Authors:  M T Davisson; K R Johnson
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse.

Authors:  C J Moen; M A van der Valk; M Snoek; B F van Zutphen; O von Deimling; A A Hart; P Demant
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

3.  Intracisternal A-particle-specific oligonucleotides provide multilocus probes for genetic linkage studies in the mouse.

Authors:  J A Mietz; E L Kuff
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 4.  Mouse map of paralogous genes.

Authors:  J H Nadeau; M Kosowsky
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 5.  Mouse chromosome 4.

Authors:  R Blank; J Eppig; F T Fiedorek; W N Frankel; J M Friedman; K Huppi; I Jackson; B Mock
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

6.  Segregation patterns of endogenous mouse mammary tumor viruses in five recombinant inbred strain sets.

Authors:  B K Lee; E M Eicher
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  A standardized nomenclature for endogenous mouse mammary tumor viruses.

Authors:  C Kozak; G Peters; R Pauley; V Morris; R Michalides; J Dudley; M Green; M Davisson; O Prakash; A Vaidya
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Ly-33: a new lymphocyte alloantigen controlled by a gene linked to Ly-17 locus on mouse chromosome 1.

Authors:  S Kimura; N Tada; J Furze; H Festenstein
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

9.  Ly-29: a locus closely linked to Mtv-20 on chromosome 4 codes for a new mouse lymphocyte surface alloantigen.

Authors:  L J Gonez; M S Sandrin; M M Henning; J Hilgers; I F McKenzie
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

10.  Biochemical similarity of Ly-19, Ly-32, and Lyb-2 alloantigens encoded in the gene cluster on mouse chromosome 4.

Authors:  S Nakamura; S Ikegami; K Dairiki; M Kochiya; T Fujimori; N Tamaoki; N Tada
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.